The accompanying notes are an integral part of
the unaudited condensed financial statements.
The accompanying notes are an integral part of
the unaudited condensed financial statements.
The accompanying notes are an integral part of
the unaudited condensed financial statements.
NOTES
TO CONDENSED FINANCIAL STATEMENTS
MARCH
31, 2017
(Unaudited)
NOTE 1. DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
Atlantic Alliance Partnership Corp. (the “Company”)
is a blank check company incorporated in the British Virgin Islands on January 14, 2015. The Company was formed for the purpose
of acquiring, engaging in a share exchange, share reconstruction and amalgamation, contractual control arrangement with, purchasing
all or substantially all of the assets of, or engaging in any other similar initial business combination with one or more businesses
or entities (“Business Combination”).
At March 31, 2017, the Company had not yet commenced
any operations. All activity through March 31, 2017 related to the Company’s formation, its Initial Public Offering, which
is described below, identifying a target company and engaging in due diligence for a Business Combination.
The registration statement for the Company’s
initial public offering (“Initial Public Offering”) was declared effective on April 28, 2015. On May 4, 2015, the Company
consummated the Initial Public Offering of 7,687,500 ordinary shares, no par value per share (“Public Shares”), which
includes a partial exercise by the underwriters of their over-allotment option of 187,500 ordinary shares, at $10.00 per Public
Share, generating gross proceeds of $76,875,000.
Simultaneously with the closing of the Initial
Public Offering, the Company consummated the sale of 778,438 ordinary shares (the “Private Placement Shares”) at a
price of $10.00 per share in a private placement to the Company’s sponsor, AAP Sponsor (PTC) Corp., a British Virgin Islands
company (“AAP Sponsor”), generating gross proceeds of $7,784,380, which is described in Note 4.
Transaction costs amounted to $5,907,302, consisting
of $2,690,625 of underwriting fees, $2,690,625 of deferred underwriting fees (which were waived by the underwriter (see Note 6))
and $526,052 of Initial Public Offering costs. In addition, as of March 31, 2017, cash held outside of the Trust Account and available
for working capital purposes amounted to $509,997.
Following the closing of the Initial Public
Offering on May 4, 2015, an amount of $80,718,750 ($10.50 per Public Share) from the net proceeds of the sale of the Public Shares
in the Initial Public Offering and the Private Placement Shares was placed in a trust account (“Trust Account”) and
invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940,
as amended (the “1940 Act”), with a maturity of 180 days or less or in any open-ended investment company that holds
itself out as a money market fund selected by the Company meeting the conditions of paragraphs (c)(2), (c)(3) and (c)(4) of Rule
2a-7 of the 1940 Act, as determined by the Company, until the earlier of: (i) the consummation of a Business Combination or (ii)
the distribution of the Trust Account as described below.
On November 1, 2016, the Company’s shareholders
approved (a) to extend the period of time for which the Company is required to consummate a Business Combination until November
3, 2017 and (b) removing the prohibition on the Company’s offering to redeem public shares held by AAP Sponsor or its affiliates,
directors or officers in connection with the consummation of a Business Combination (the “Extension Amendment”). The
number of ordinary shares presented for redemption in connection with the Extension Amendment was 6,976,958. The Company paid cash
in the aggregate amount of $73,443,711, or approximately $10.53 per share, to redeeming shareholders. As a result of the payment
on the ordinary shares presented for redemption in connection with the Extension Amendment, cash and marketable securities held
in the trust account decreased to $7,484,172. In addition, on November 1, 2016, an aggregate of $144,602 was distributed as a cash
dividend payment to shareholders that voted to approve the Extension Amendment, which amount is equal to $0.02 for each of the
7,230,088 public shares of the Company that was voted to approve the Extension Amendment. The cash payment did not come from the
Company’s Trust Account but was paid from funds loaned to the Company by AAP Sponsor.
The Company’s management has broad discretion
with respect to the specific application of the net proceeds of its Initial Public Offering and Private Placement Shares, although
substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. The Company’s
Public Shares are listed on the Nasdaq Capital Market (“NASDAQ”). Pursuant to the NASDAQ listing rules, the Company’s
Business Combination must be with a target business or businesses whose collective fair market value is equal to at least 80% of
the balance in the Trust Account at the time of the execution of a definitive agreement for such Business Combination. There is
no assurance that the Company will be able to successfully effect a Business Combination.
The Company will provide its shareholders with
the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in
connection with a shareholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision
as to whether the Company will seek shareholder approval of a Business Combination or conduct a tender offer will be made by the
Company, solely in its discretion. The per-share price of the Public Shares to be redeemed, payable in cash, will be equal to
the aggregate amount then on deposit in the Trust Account as of two business days prior to the consummation of a Business Combination
including interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations,
divided by the number of then outstanding Public Shares. However, in no event will the Company redeem its Public Shares in an
amount that would cause its net tangible assets to be less than $5,000,001. The Company’s initial shareholder has agreed
to waive its redemption rights with respect to its founder shares (as defined in Note 5), Private Placement Shares and Public
Shares in connection with the completion of a Business Combination. If a shareholder vote is not required by law and the Company
does not decide to hold a shareholder vote for business or other legal reasons, the Company will, pursuant to its Amended Memorandum
and Articles of Association, conduct the redemptions pursuant to the tender offer rules of the Securities and Exchange Commission
(“SEC”), and file tender offer documents with the SEC prior to completing a Business Combination.
ATLANTIC
ALLIANCE PARTNERSHIP CORP.
NOTES
TO CONDENSED FINANCIAL STATEMENTS
MARCH
31, 2017
(Unaudited)
If, however, a shareholder approval of the transaction
is required by law, or the Company decides to obtain shareholder approval for business or other legal reasons, the Company will
offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer
rules. If the Company seeks shareholder approval, it will complete a Business Combination only if a majority of the outstanding
ordinary shares voted are voted in favor of the Business Combination. Each public shareholder may elect to redeem their Public
Shares irrespective of whether they vote for or against the proposed transaction.
If the Company seeks shareholder approval in
connection with a Business Combination, the initial shareholder has agreed to vote its founder shares, Private Placement Shares
and any Public Shares purchased during or after the Initial Public Offering in favor of a Business Combination.
If the Company seeks shareholder approval of
a Business Combination and it does not conduct redemptions in connection with a Business Combination pursuant to the tender offer
rules, the Company’s Amended Memorandum and Articles of Association provides that a public shareholder, together with any
affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as
defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), will be restricted
from redeeming its shares with respect to more than an aggregate of 20% of the shares sold in the Initial Public Offering (“Excess
Shares”). However, the Company would not be restricting the shareholders’ ability to vote all of their shares (including
Excess Shares) for or against a Business Combination.
In connection with the Extension Amendment approved
by the Company’s shareholders on November 1, 2016, the Company has until November 3, 2017 (the “Combination Period”)
to complete a Business Combination. However, if the Company is unable to complete a Business Combination by the Combination Period,
the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but no
more than ten business days thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate
amount then on deposit in the Trust Account including interest earned on the funds held in the Trust Account and not previously
released to the Company to pay its tax obligations (less up to $100,000 of interest to pay dissolution expenses), divided by the
number of then outstanding Public Shares, which redemption will completely extinguish public shareholders’ rights as shareholders
(including the right to receive further liquidation distributions, if any), subject to applicable law, and (iii) as promptly as
reasonably possible following such redemption, subject to the approval of the remaining shareholders and the Company’s board
of directors, proceed to commence a voluntary liquidation and thereby a formal dissolution of the Company, subject in each case
to its obligations to provide for claims of creditors and the requirements of the laws of the British Virgin Islands and other
applicable law.
The initial shareholder has agreed to waive its rights
to liquidating distributions from the Trust Account with respect to its founder shares and Private Placement Shares if the Company
fails to complete a Business Combination during the Combination Period. However, if the initial shareholder acquires Public Shares
in or after the Initial Public Offering, it will be entitled to liquidating distributions from the Trust Account with respect to
such Public Shares if the Company fails to complete a Business Combination within the Combination Period. In the event of such
distribution, it is possible that the per share value of the residual assets remaining available for distribution (including Trust
Account assets) will be less than the approximately $10.53 per Public Share held in the Trust Account. In order to protect the
amounts held in the Trust Account, Messrs. Jonathan Goodwin, Iain Abrahams, Mark Klein, Waheed Alli and Jonathan Mitchell, the
Company’s management team, have agreed that they will be jointly and severally liable to the Company if and to the extent
any claims by a vendor for services rendered or products sold to the Company, or a prospective target business with which the Company
has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account. This liability will not apply
with respect to any claims by a third party who executed a waiver of any and all rights to seek access to the Trust Account and
except as to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain
liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). Moreover, in
the event that an executed waiver is deemed to be unenforceable against a third party, then Messrs. Abrahams, Klein, and Mitchell
will not be responsible to the extent of any liability for such third party claims.
On November 1, 2016, the Company amended certain
letter agreements, dated as of April 28, 2015, by and among the Company and AAP Sponsor, officers and directors (the “Insiders”
and such letter agreements, the “Letter Agreements”) pursuant to which (1) the Insiders shall be entitled to redemption
and liquidation rights, as applicable, with respect to any ordinary shares of the Company (other than founder shares, Private Placement
Shares and Conversion Shares) they hold (i) if the Company fails to consummate a Business Combination by November 3, 2017 or (ii)
in connection with the consummation of a Business Combination and (2) the Insiders shall not have the right to vote any ordinary
shares of the Company issuable upon conversion of convertible debt of the Company held by the Insiders in connection with a Business
Combination (including the Conversion Shares).
ATLANTIC
ALLIANCE PARTNERSHIP CORP.
NOTES
TO CONDENSED FINANCIAL STATEMENTS
MARCH
31, 2017
(Unaudited)
NOTE 2. LIQUIDITY AND GOING CONCERN
As of March 31, 2017,
the Company had $509,997 in its operating bank accounts, $7,484,172 in cash and securities held in the Trust Account to be used
for a Business Combination or to repurchase or redeem its ordinary shares in connection therewith and working capital of $394,454.
As of March 31, 2017, approximately $23,000 of the amount on deposit in the Trust Account represented interest income, which is
available to pay the Company’s tax obligations.
Until the consummation of a Business Combination,
the Company will be using the funds not held in the Trust Account for identifying and evaluating prospective acquisition candidates,
performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to acquire,
and structuring, negotiating and consummating the Business Combination.
The Company may need to raise additional capital through
loans or additional investments from AAP Sponsor, its shareholders, officers, directors, or third parties. None of the shareholders,
officers or directors, AAP Sponsor or third parties is under any obligation to advance funds to, or to invest in, the Company.
Accordingly, the Company may not be able to obtain additional financing. If the Company is unable to raise additional capital,
it may be required to take additional measures to conserve liquidity, which could include, but not necessarily be limited to, curtailing
operations, suspending the pursuit of a potential transaction, and reducing overhead expenses. The Company cannot provide any assurance
that new financing will be available to it on commercially acceptable terms, if at all. These conditions raise substantial doubt
about the Company’s ability to continue as a going concern through November 3, 2017, the date the Company is required to
liquidate. These financial statements do not include any adjustments relating to the recovery of the recorded assets or the classification
of the liabilities that might be necessary should the Company be unable to continue as a going concern.
On March 29, 2017, the Company
received a written notice (the “Notice”) from the Listing Qualifications Department of Nasdaq indicating that the staff
of Nasdaq has determined that the Company currently does not comply with Listing Rule 5550(a)(3) (the “Minimum Holders Rule”),
which requires the Company to have at least 300 public holders of its ordinary shares for continued listing on Nasdaq.
The Notice stated that, no
later than May 15, 2017, the Company is required to submit a plan to regain compliance with the Minimum Holders Rule. The Company
intends to submit a plan with Nasdaq on or before May 15, 2017 to regain compliance and maintain its Nasdaq listing. If Nasdaq
accepts the Company’s plan, Nasdaq may grant the Company an extension of up to 180 calendar days from the date of the Notice
to evidence compliance with the Minimum Holders Rule. If Nasdaq does not accept the Company’s plan, the Company will have
the opportunity to appeal the decision in front of a Nasdaq Hearings Panel.
NOTE 3. SUMMARY OF SIGNIFICANT ACCOUNTING
POLICIES
Basis of presentation
The accompanying unaudited condensed financial
statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”)
for interim financial information and in accordance with the instructions to Form 10-Q and Article 10 of Regulation S-X of the
SEC. Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have
been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they
do not include all the information and footnotes necessary for a comprehensive presentation of financial position, results of operations,
or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments,
consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results
and cash flows for the periods presented.
The accompanying unaudited condensed financial
statements should be read in conjunction with the Company's Annual Report on Form 10-K for the year ended December 31, 2016 as
filed with the SEC on March 15, 2017, which contains the audited financial statements and notes thereto, together with Management’s
Discussion and Analysis. The financial information as of December 31, 2016 is derived from the audited financial statements presented
in the Company’s Annual Report on Form 10-K for the year ended December 31, 2016. The interim results for the three months
ended March 31, 2017 are not necessarily indicative of the results to be expected for the year ending December 31, 2017 or for
any future interim periods.
ATLANTIC
ALLIANCE PARTNERSHIP CORP.
NOTES
TO CONDENSED FINANCIAL STATEMENTS
MARCH
31, 2017
(Unaudited)
Emerging growth company
The Company is an “emerging growth company,”
as defined in Section 2(a) of the Securities Act of 1933, as amended, (the “Securities Act”), as modified by the Jumpstart
Our Business Startups Act of 2012, (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting
requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to,
not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure
obligations regarding executive compensation in our periodic reports and proxy statements, and exemptions from the requirements
of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously
approved.
Further, section 102(b)(1) of the JOBS Act exempts
emerging growth companies from being required to comply with new or revised financial accounting standards until private companies
(that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities
registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act
provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging
growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition
period which means that when a standard is issued or revised and it has different application dates for public or private companies,
the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or
revised standard. This may make comparison of the Company’s financial statements with another public company which is neither
an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult
or impossible because of the potential differences in accounting standards used.
Use of estimates
The preparation of financial statements in conformity
with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and
disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and
expenses during the reporting period.
Making estimates requires management to exercise
significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances
that existed at the date of the financial statements, which management considered in formulating its estimate, could change in
the near term due to one or more future events. Accordingly, the actual results could differ significantly from those estimates.
Cash equivalents
The Company considers all short-term investments
with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents
as of March 31, 2017 and December 31, 2016.
Cash and marketable securities held in Trust Account
At March 31, 2017 and December 31, 2016, the
assets held in the Trust Account were held in cash and U.S. Treasury Bills, which are classified as trading securities.
Ordinary shares subject to possible redemption
The Company accounts for its ordinary shares
subject to possible redemption in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480
“Distinguishing Liabilities from Equity.” Ordinary shares subject to mandatory redemption (if any) are classified as
a liability instrument and are measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that
feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain
events not solely within the Company’s control) are classified as temporary equity. At all other times, ordinary shares are
classified as shareholders’ equity. The Company’s ordinary shares feature certain redemption rights that are considered
to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, at March 31, 2017
and December 31, 2016, ordinary shares subject to possible redemption are presented as temporary equity, outside of the shareholders’
equity section of the Company’s balance sheets.
Net loss per share
The Company complies with accounting and disclosure
requirements of ASC Topic 260, “Earnings Per Share.” Net loss per share is computed by dividing net loss by the weighted
average number of ordinary shares outstanding during the period. Ordinary shares subject to possible redemption at March 31, 2017
and 2016 have been excluded from the calculation of basic loss per share since such shares, if redeemed, only participate in their
pro rata share of the Trust Account earnings. At March 31, 2017 and 2016, the Company did not have any dilutive securities and
other contracts that could, potentially, be exercised or converted into ordinary shares and then share in the earnings of the
Company. As a result, diluted loss per share is the same as basic loss per share for the periods presented.
ATLANTIC
ALLIANCE PARTNERSHIP CORP.
NOTES
TO CONDENSED FINANCIAL STATEMENTS
MARCH
31, 2017
(Unaudited)
Income taxes
The Company complies with the accounting and
reporting requirements of ASC Topic 740, “Income Taxes,” which requires an asset and liability approach to financial
accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the
financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on
enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation
allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.
ASC Topic 740 prescribes a recognition threshold
and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken
in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination
by taxing authorities. The Company’s management determined that the British Virgin Islands is the Company’s only major
tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense.
As of March 31, 2017, there were no amounts accrued for interest and penalties. There were no unrecognized tax benefits as of March
31, 2017. The Company is currently not aware of any issues under review that could result in significant payments, accruals or
material deviation from its position.
The Company may be subject to potential examination
by U.S. federal, U.S. states or foreign taxing authorities in the areas of income taxes. These potential examinations may include
questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with U.S. federal,
U.S. state and foreign tax laws. The Company’s management does not expect that the total amount of unrecognized tax benefits
will materially change over the next twelve months.
The Company’s tax provision is zero because
the Company is organized in the British Virgin Islands with no connection to any other taxable jurisdiction. The Company is considered
to be an exempted British Virgin Islands Company, and is presently not subject to income taxes or income tax filing requirements
in the British Virgin Islands or the United States.
Concentration of credit risk
Financial instruments that potentially subject
the Company to concentration of credit risk consist of cash accounts in a financial institution which, at times may exceed the
Federal depository insurance coverage of $250,000. At March 31, 2017 and December 31, 2016, the Company had not experienced losses
on these accounts and management believes the Company is not exposed to significant risks on such accounts.
Fair value of financial instruments
The fair value of the Company’s assets
and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurements and Disclosures,”
approximates the carrying amounts represented in the accompanying balance sheets, primarily due to their short-term nature.
Recent Accounting Pronouncements
Management does not believe that any recently
issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company's financial
statements.
NOTE 4. PRIVATE PLACEMENT
Simultaneously with the Initial Public Offering,
AAP Sponsor purchased an aggregate of 778,438 Private Placement Shares at a purchase price of $10.00 per share from the Company
in a private placement. The proceeds from the Private Placement Shares were added to the net proceeds from the Initial Public Offering
held in the Trust Account.
If the Company does not complete a Business
Combination within the Combination Period, the proceeds of the sale of the Private Placement Shares will be used to fund the redemption
of the Company’s Public Shares (subject to the requirements of applicable law). The Private Placement Shares are identical
to the founder shares, except that AAP Sponsor has agreed not to transfer, assign or sell any of the Private Placement Shares until
the date that is 30 days after the date the Company completes a Business Combination.
ATLANTIC
ALLIANCE PARTNERSHIP CORP.
NOTES
TO CONDENSED FINANCIAL STATEMENTS
MARCH
31, 2017
(Unaudited)
NOTE 5. RELATED PARTY TRANSACTIONS
Founder Shares
On January 15, 2015, the Company issued 2,156,250
ordinary shares to the AAP Sponsor (the “founder shares”) for an aggregate purchase price of $25,000. The 2,156,250
founder shares included an aggregate of up to 281,250 shares subject to forfeiture by the initial shareholder (or its permitted
transferees) on a pro rata basis depending on the extent to which the underwriters’ over-allotment option was exercised.
As a result of the underwriters’ election to exercise their over-allotment option to purchase 187,500 ordinary shares on
May 4, 2015, 46,875 founder shares were no longer subject to forfeiture.
The remaining portion of the underwriters’
over-allotment was extinguished; accordingly, 234,375 founder shares were forfeited. The founder shares are identical to the Public
Shares sold in the Initial Public Offering, except that (1) the founder shares are subject to certain transfer restrictions, as
described in more detail below, and (2) the initial shareholder has agreed (i) to waive its redemption rights with respect to its
founder shares, Private Placement Shares and Public Shares purchased during or after the Initial Public Offering in connection
with the completion of a Business Combination and (ii) to waive its rights to liquidating distributions from the Trust Account
with respect to its founder shares and Private Placement Shares if the Company fails to complete a Business Combination within
the Combination Period.
The founder shares may not be transferred, assigned
or sold until one year after the date of the consummation of a Business Combination or earlier if, subsequent to a Business Combination,
(i) the last sale price of the Company’s ordinary shares equals or exceeds $12.00 per share (as adjusted for stock splits,
stock dividends, reorganizations and recapitalizations) for any 20 trading days within any 30-trading day period commencing at
least 150 days after a Business Combination or (ii) the Company consummates a subsequent liquidation, merger, stock exchange or
other similar transaction which results in all of the shareholders having the right to exchange their ordinary shares for cash,
securities or other property (the “Lock-Up Period”).
Promissory Notes – Related Party
During the year ended December 31, 2016, the
Company received an aggregate of $2,852,000 in advances from certain directors of the Company or their affiliates (through AAP
Sponsor). The advances were non-interest bearing, unsecured and to be repaid upon the completion of a Business Combination.
On November 1, 2016, (i) an aggregate of $1,000,000
of outstanding advances from certain directors of the Company or their affiliates (through AAP Sponsor) were converted into ordinary
shares of the Company at a conversion price of $10.00 per share and (ii) an aggregate of $1,852,000 of outstanding advances from
certain directors of the Company or their affiliates were converted into ordinary shares of the Company at a conversion price of
approximately $10.50 per share. In the aggregate, 276,378 ordinary shares (the “Conversion Shares”) were issued to
AAP Sponsor in connection with such conversions. AAP Sponsor shall not be entitled to (i) vote such Conversion Shares in connection
with a Business Combination or (ii) redeem such Conversion Shares in connection with the liquidation of the Company.
NOTE 6. COMMITMENTS AND CONTINGENCIES
Registration Rights
Pursuant to a registration rights agreement
entered into on April 28, 2015 with the holders of the founder shares and Private Placement Shares, the holders of the majority
of these securities are entitled to make up to three demands, excluding short form demands, that the Company register such securities
and shares that may be issued upon conversion of Working Capital Loans. In addition, the holders have certain “piggy-back”
registration rights with respect to registration statements filed subsequent to the completion of a Business Combination and rights
to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act. However, the registration
rights agreement provides that the Company will not permit any registration statement filed under the Securities Act to become
effective until termination of the applicable Lock-Up Period. The Company will bear the expenses incurred in connection with the
filing of any such registration statements.
Underwriting Agreement
The underwriters were entitled to an underwriting
discount of 7.0%, or $5,381,250, of which three and one-half percent (3.5%), or $2,690,625, was paid in cash at the closing of
the Initial Public Offering on May 4, 2015, and up to three and one-half percent (3.5%), or $2,690,625, had been deferred. The
deferred fee was payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completed
a Business Combination, subject to the terms of the underwriting agreement.
On November 1, 2016, the representative of the
underwriters waived its right to receive its deferred fee in the amount of $2,690,625, which had been held in the Trust Account.
Accordingly, no further payments will be due and payable to the underwriters by the Company in the event that the Company completes
a Business Combination.
ATLANTIC
ALLIANCE PARTNERSHIP CORP.
NOTES
TO CONDENSED FINANCIAL STATEMENTS
MARCH
31, 2017
(Unaudited)
NOTE 7. SHAREHOLDERS’ EQUITY
Preferred Shares -
The Company
is authorized to issue an unlimited number of no par value preferred shares, divided into five classes, Class A through Class E
each with such designation, rights and preferences as may be determined by a resolution of the Company’s board of directors
to amend the Amended Memorandum and Articles of Association to create such designations, rights and preferences. The Company has
five classes of preferred shares to give the Company flexibility as to the terms on which each Class is issued. All shares of a
single class must be issued with the same rights and obligations. Accordingly, starting with five classes of preferred shares will
allow the Company to issue shares at different times on different terms. At March 31, 2017, there are no preferred shares designated,
issued or outstanding.
Ordinary Shares -
The Company
is authorized to issue an unlimited number of no par value ordinary shares. Holders of the Company’s ordinary shares are
entitled to one vote for each share. At March 31, 2017, there were 3,413,938 ordinary shares issued and outstanding (excluding
273,295 ordinary shares subject to possible redemption).
NOTE 8. FAIR VALUE MEASUREMENTS
The Company follows the guidance in ASC 820
for its financial assets and liabilities that are re-measured and reported at fair value at each reporting period, and non-financial
assets and liabilities that are re-measured and reported at fair value at least annually.
The fair value of the Company’s financial
assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with
the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants
at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize
the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal
assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify
assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities:
|
Level 1:
|
Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis.
|
|
|
|
|
Level 2:
|
Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active.
|
|
|
|
|
Level 3:
|
Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability.
|
The following table presents information about
the Company’s assets that are measured at fair value on a recurring basis at March 31, 2017 and December 31, 2016, and indicates
the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:
Description
|
|
Level
|
|
|
March 31,
2017
|
|
|
December 31,
2016
|
|
Assets:
|
|
|
|
|
|
|
|
|
|
Cash and marketable securities held in Trust Account
|
|
1
|
|
|
$
|
7,484,172
|
|
|
$
|
7,479,598
|
|
NOTE 9. SUBSEQUENT EVENTS
The Company evaluates subsequent events
and transactions that occur after the balance sheet date up to the date that the financial statements were issued. Other than
as described below, the Company did not identify subsequent events that would have required adjustment or disclosure in the financial
statements.
On May 8, 2017, the Company announced
that it entered into a merger agreement (the “Merger Agreement”) with Kalyx Development, Inc., a private real estate
investment trust focused on owning and operating commercial real estate facilities leased to cultivators, processors and/or distributors
in the regulated U.S. cannabis industry (“Kalyx”), pursuant to which Kalyx will merge with an into the Company (the
“Merger”) after the Company first converts from a British Virgin Islands company to a Maryland real estate investment
trust. The surviving public company, which is expected to be organized as a Maryland corporation, will be re-named Kalyx Properties
Inc. (“KPI”).
In connection with and as a condition
to the closing of the Merger, the Company expects to conduct a private placement of its common stock to accredited investors (the
“PIPE”). As a further condition to the closing of the Merger, the proceeds of the PIPE, when combined with cash currently
in the Company’s Trust Account (subject to potential Company shareholder redemptions), will be required to equal or exceed
$15 million. The proceeds are anticipated to be used by KPI to make additional real estate acquisitions and for general working
capital purposes.
Pursuant to the Merger, all shareholders
of Kalyx will receive shares of KPI based on the Company’s aggregate pre-money equity valuation of Kalyx with the shares
to be issued by KPI being valued at $10 per share and holders of Kalyx warrants who do not elect to exchange such warrants for
shares of Kalyx common stock (as described in the Merger Agreement) will have their warrants assumed by KPI (subject to a minimum
threshold of such warrants being amended (as described in the Merger Agreement)). Shareholders of the Company who do not elect
to redeem their ordinary shares will receive a stock dividend immediately prior to the closing based on the difference between
the Trust Account liquidation value per share at the closing of the Merger and the $10 per share price. AAP Sponsor has agreed
to forfeit a portion of the KPI shares that it would receive in the Merger for its founder shares.